Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disease that is often refractory to surgery and requires treatment with biologics, including dupilumab (DUP), a monoclonal antibody targeting IL-4/13. Here, IL4 is linked to chronic rhinosinusitis.